Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident

Oncogene

Volumn 13, Issue 4, 1996, Pages 687-693

  Nikiforov, Yuri E ^a,b   Nikiforova, Marina N ^a,b   Gnepp, Douglas R ^c   Fagin, James A ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

Chernobyl; p53; Radiation; ras; Thyroid tumors

Indexed keywords

OLIGONUCLEOTIDE; PROTEIN P53;

ARTICLE; CHERNOBYL ACCIDENT; CHILD; CHILDHOOD CANCER; FOLLICULAR CARCINOMA; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MISSENSE MUTATION; ONCOGENE RAS; PAPILLARY CARCINOMA; POINT MUTATION; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; SINGLE STRAND CONFORMATION POLYMORPHISM; THYROID TUMOR; TUMOR SUPPRESSOR GENE;

ACCIDENTS, RADIATION; ADOLESCENT; ADULT; BASE SEQUENCE; CHILD; DNA PRIMERS; GENES, P53; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS, RADIATION-INDUCED; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; POWER PLANTS; THYROID NEOPLASMS; UKRAINE;

EID: 0029785721     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bogdanova T, Bragarnik M, Tronco ND, Harach HR, Thomas GA and Williams ED. (1995). Thyroid, 5, Suppl. 1, S-28, (Abstract).
2. Challeton C, Bounacer A, Du Villard JA, Caillou B, De Vathaire F, Monier R, Schlumberger M and Suarez HG. (1995). Oncogene, 11, 601-603.
3. Chen CH, Endlich B, Salavati R and Ling CC. (1993). Cancer Res., 53, 1511-1515.
4. Conard RA, Asteris GT, Dobyns BM and Sutow WW. (1970). JAMA, 214, 316-324.
5. Denko NC, Giaccia AJ, Stringeg JR and Stambrook PJ. (1994). Proc. Natl. Acad. Sci. USA, 91, 5124-5128.
6. Denko N, Stringer J, Wani M and Stambrook P. (1995). Somatic Cell & Mol. Genetics, 21, 241-253.
7. Dobyns BN and Hyrmer BA. (1992). World J. Surg., 16, 126-140.
8. Donghi R, Longoni A, Pilotti S, Michieli P, Della Porta G and Pierotti MA. (1993). J. Clin. Invest., 91, 1753-1760.
9. Duffy BJ and Fitzgerald PJ. (1950). J. Clin. Endocrinol. Metab., 10, 1296-1308.
10. Ezaki H, Takeichi N and Yoshimoto Y. (1991). J. Radiat. Res. Suppl., 32, 193-200.
11. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang SH and Koeffler HP. (1993). J. Clin. Invest., 91, 179-184.
12. Finney RE and Bishop JM. (1993). Science, 260, 1524-1527.
13. Fugazzola L, Pilotti S, Pinchera A, Vorontsova TV, Mondellini P, Bongarzone I, Greco A, Astakhova L, Butti MG, Demidchik EP, Pacini F and Pierotti MA. (1995). Cancer Res., 55, 5617-5620.
14. Furmanchuk AW, Averkin JI, Egloff B, Ruchti C, Abelin T, Schappi W and Korotkevich EA. (1992). Histopathology, 21, 401-408.
15. Greenblatt MS, Bennett WP, Hollstein M and Harris CC. (1994). Cancer Res., 54, 4855-4878.
16. Ilyin LA, Balonov MI, Buldakov LA, Bur'yak VN, Gordeev KI, Dement'ev SI, Zhakov IG, Zubovsky GA, Kondrusev AI, Konstantinov YO, Linge II, Likhtarev IA, Lyaginskaya AM, Matyuhin VA, Pavlovsky OA, Potapov AI, Prysyazhnyuk AE, Ramsaev PV, Romanenko AE, Savkin MN, Starkova NT, Tron'ko ND and Tsyb AF. (1990). J. Radiol. Prot., 10, 13-29.
17. Ito T, Seyama T, Iwamoto KS, Hayashi T, Mizuno T, Tsuyama N, Dohi, Nakamura N and Akiyama M. (1993). Cancer Res., 53, 2940-2943.
18. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Res., 51, 6304-6311.
19. Kazakov VS, Demidchik EP and Astakhova LN. (1992). Nature, 359, 21.
20. Klugbauer S, Lengfelder E, Demidchik EP and Rabes HM. (1995). Oncogene, 11, 2459-2467.
21. Kronenberg A. (1995). Int. J. Radiat. Biol., 66, 603-605.
22. Lemoine NR, Mayall ES, Williams ED, Thurston V and Wynford-Thomas D. (1988). Oncogene, 3, 541-544.
23. Lemoine NR and Thurston V. (1989). Thyroid tumours. Molecular basis of pathogenesis. Wynford-Thomas D and Williams ED. (eds), Churchill Livingstone: London, pp. 4-37.
24. Mitsudomi T, Viallet J, Mulshine JL, Linnoila RI, Minna JD and Gazdar AF. (1991). Oncogene, 6, 1353-1362.
25. Namba H, Rubin S and Fagin JA. (1990). Mol. Endocrinol., 4, 1474-1479.
26. Nikiforov Y and Gnepp DR. (1994). Cancer, 74, 748-766.
27. Nikiforov Y, Heffess C, Korzenko A, Fagin JA and Gnepp DR. (1995). Cancer, 76, 900-909.
28. Nikiforov Y, Gnepp DR and Fagin JA. (1996). J. Clin. Endocrinol. Metab., 81, 9-14.
29. Orita M, Suzuki Y, Sekiya T and Hayashi K. (1989). Genomics, 5, 874-879.
30. Sampson RJ, Key CR, Buncher CR and Iijima S. (1969). JAMA, 209, 65-70.
31. Schneider AB, Pinsky S, Bekerman C and Ryo UY. (1980). Cancer, 46, 1218-1227.
32. Shore RE, Woodard E, Hildreth N, Dvoretsky P, Hempelmann L and Pasternack B. (1985). J. Natl. Cancer Inst., 74, 1177-1184.
33. Taylor JA, Watson MA, Devereux TR, Michels RY, Saccomanno G and Anderson M. (1993). Lancet, 343, 86-87.
34. Vahakangas KH, Samet JM, Metcalf RA, Welch JA, Bennett WP, Lane DP and Harris CC. (1992). Lancet, 339, 576-580.
35. Williams D. (1994). Nature, 371, 556.
36. Winship T and Rosvoll RV. (1970). Clin. Proc. Children's Hosp. Washington, DC., 26, 327-349.
37. Wright PA, Williams ED, Lemoine NR and WynfordThomas D. (1991). Oncogene, 6, 471-473.
38. Zhang PL, Calaf G and Russo J. (1994). Molec. Carcinogenesis, 9, 46-56.